Project Grant R36DA065049
Award Date 8/15/26
Completion Date 7/31/28
Dollars Obligated $107K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Emigration Canyon, UT 84108, USA
Similar Awards
- The National Institute on Drug Abuse awarded the University of Utah $1,442,744 on August 15, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct the Co-Use of Opioids and Alcohol Prevention Study (COAPS) 2.0. The award funds a hybrid type-2 implementation effectiveness study designed to scale an alcohol-targeted brief intervention-medication therapy management (ABI-MTM) intervention across community pharmacy settings. The study will execute a three-pronged...
- The National Institute on Drug Abuse awarded the University of Miami $164,766 on August 19, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct implementation research on telehealth models for HIV and substance use disorder care among people who inject drugs. The research, guided by the Implementation Research Logic Model, will explore patterns of existing healthcare services at organizations serving people who inject drugs nationwide and identify implementation...
- The National Institute on Drug Abuse awarded the University of Utah $423,500 on July 15, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop and test a remote collaborative care-facilitated contingency management program integrated with cardiac rehabilitation for individuals with methamphetamine-associated congestive heart failure and methamphetamine-associated pulmonary arterial hypertension. The project addresses the growing prevalence of cardiopulmonary...
- The National Institute on Drug Abuse, a component of the Department of Health and Human Services National Institutes of Health, awarded the University of Utah $154,536 on August 20, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct longitudinal social network analysis research on Native mothers navigating substance use disorder and perinatal care. The University of Utah, through its Office of Sponsored Projects Division, will characterize the social networks of...
- The National Institute on Drug Abuse awarded the University of Utah $162,200 on October 10, 2025, under the Drug Use and Addiction Research Programs (CFDA 93.279) to characterize pain embodiment and its relationship to opioid misuse risk in chronic pain using neuroimaging. The award funds a five-year research project through September 30, 2030, performed in Salt Lake City, Utah. The research will employ resting-state functional magnetic resonance imaging to study pain embodiment—the tendency...
- The National Institute on Drug Abuse awarded $709,085 to The Regents of the University of Colorado, doing business as University of Colorado-Denver, on April 1, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279). The award funds an implementation trial testing in-hospital opioid treatment program (OTP) intakes to facilitate linkage from hospitalization to outpatient methadone treatment among patients with opioid use disorder. The study uses a staircase cluster randomized...
- The National Institute on Drug Abuse, a component of the Department of Health and Human Services National Institutes of Health, awarded the University of Utah $462,000 on June 1, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop photochemical tools for investigating neuropeptide modulation during methamphetamine withdrawal. The project will engineer a modular library of cyclic, photolabile caging scaffolds that render corticotropin releasing factor (CRF),...
- The National Institute on Drug Abuse awarded the Board of Regents of Nevada System of Higher Education (University of Nevada, Reno) $402,205 on May 1, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279). The award funds a research study examining medication for opioid use disorder (MOUD) access and treatment outcomes among individuals dually enrolled in Medicare and Medicaid. The research uses Medicare Advantage utilization and prescription claims data from 2021–2024 alongside...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded $431,643 under its Drug Use and Addiction Research Programs (CFDA 93.279) to The Research Foundation for the State University of New York (SUNY at Binghamton) on August 1, 2025, for a two-year project concluding July 31, 2027. This Project Grant funds the development and pilot testing of a telehealth-delivered, pain-targeted motivational smoking intervention designed for smokers with chronic pain who are not ready to...
- The National Institute on Drug Abuse awarded The Trustees of Columbia University in the City of New York $2.943 million on September 15, 2025, under Drug Use and Addiction Research Programs (CFDA 93.279) to conduct a longitudinal study examining the impact of cannabis use disorder and its treatment on opioid-related health consequences in Veterans Health Administration patients. The research will investigate associations between cannabis use disorder (CUD) and opioid use disorder (OUD),...